Caplight Directory>Investors>EQT Life Sciences>Eqt-life-sciences


EQT Life Sciences

EQT Life Sciences

Amsterdameqtgroup.com

Overview

EQT Life Sciences is a venture capital firm that invests in companies operating in the healthcare, life sciences, oncology, internet of things, and health technology sectors across the United States and Europe.

Year Founded

1988

Portfolio Companies

83

Investments

CompanyDateStageLead
Neurent MedicalFeb 2026Series CCo-investor
Tenpoint TherapeuticsJan 2026Series BCo-investor
Exciva GmbHJan 2026Series BLead
Kinaset TherapeuticsJan 2026Series BCo-investor
FoRx TherapeuticsDec 2025Series ACo-investor
View all investments

Key People

Per Franzen

CEO And Managing Partner

Fouad Azzam

General Partner

Isidoor Rutten

Managing Director

Polly Barnes

Operating Partner - Talent

Albert Gustafsson

Partner

Alex Lee

Partner

Ali Farahani

Partner

Andreas Dr. Fischer

Partner

Anne Portwich

Partner

Asís Echániz

Partner

Carlos Santana

Partner

Carolina Brochado

Partner

Caspar Callerström

Partner

Crosby Cook

Partner

Dominik Stein

Partner

Ethan Waxman

Partner

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersAmsterdam
Year Founded1988

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.